ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208734; 2) Community: the network communities that were significantly associated with the response to NSC 208734; 3) Molecule: the relationships between components within communities and NSC 208734; 4) MDR: the compounds that were significantly associated with the NSC 208734.

NSC Compound Enrichment Correlation
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.00347157511980527 0.34176234
NSC 758664 Sirolimus [USAN] 0.00347157511980527 -0.10850496
NSC 131020 Null 0.00404192617431249 0.4142017
NSC 132483 Aminopterin Derivative 0.00404192617431249 0.44847409
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00404192617431249 0.21761943
NSC 284751 Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate) 0.00404192617431249 0.45478448
NSC 341936 Adenosine, 2-bromo-2'-deoxy- 0.00404192617431249 0.11751854
NSC 618939 Camptothecin Derivative 0.00404192617431249 0.35061083
NSC 626108 Null 0.00404192617431249 0.015008692
NSC 676372 Null 0.00404192617431249 -0.0080546125
Total:69  Current:8    [First] [Prev] [Next] [Last]